| Host: |
Rabbit |
| Applications: |
WB/ELISA |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Bcl-2-related protein A1 is suitable for use in Western Blot and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000ELISA 1:5000-20000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
BCL2A1 |
| Gene ID: |
597 |
| Uniprot ID: |
B2LA1_HUMAN |
| Specificity: |
B2LA1 Polyclonal Antibody detects endogenous levels of protein. |
| Immunogen: |
Synthesized peptide derived from part of the human protein |
| Function | Retards apoptosis induced by IL-3 deprivation. May function in the response of hemopoietic cells to external signals and in maintaining endothelial survival during infection. Can inhibit apoptosis induced by serum starvation in the mammary epithelial cell line HC11. |
| Protein Name | Bcl-2-Related Protein A1Bcl-2-Like Protein 5Bcl2-L-5Hemopoietic-Specific Early Response ProteinProtein Bfl-1Protein Grs |
| Database Links | Reactome: R-HSA-9725371 |
| Cellular Localisation | Cytoplasm |
| Alternative Antibody Names | Anti-Bcl-2-Related Protein A1 antibodyAnti-Bcl-2-Like Protein 5 antibodyAnti-Bcl2-L-5 antibodyAnti-Hemopoietic-Specific Early Response Protein antibodyAnti-Protein Bfl-1 antibodyAnti-Protein Grs antibodyAnti-BCL2A1 antibodyAnti-BCL2L5 antibodyAnti-BFL1 antibodyAnti-GRS antibodyAnti-HBPA1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
